E-drug: Antidepressant Nefazodone discontinued in Canada
-------------------------------------------------------------------------
Discontinuation of Sales of Nefazodone in Canada
It has come to the attention of Health Canada that nefazodone has
been associated with adverse hepatic events including liver failure
requiring transplantation in Canada.
Following discussions with Health Canada, Bristol-Myers Squibb
Canada has decided to discontinue sales of nefazodone, effective
November 27, 2003.
During this transitional period, healthcare providers are asked to
arrange alternative therapies other than nefazodone for their
patients.
http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/bms_nefazodone_2_hp
c_e.html
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug